Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases

Mov Disord. 2019 Sep;34(9):1315-1324. doi: 10.1002/mds.27728. Epub 2019 May 28.

Abstract

Background: Retinal optical coherence tomography findings in Lewy body diseases and their implications for visual outcomes remain controversial. We investigated whether region-specific thickness analysis of retinal layers could improve the detection of macular atrophy and unravel its association with visual disability in Parkinson's disease.

Methods: Patients with idiopathic Parkinson's disease (n = 63), dementia with Lewy bodies (n = 8), and E46K mutation carriers in the α-synuclein gene (E46K-SNCA) (n = 4) and 34 controls underwent Spectralis optical coherence tomography macular scans and a comprehensive battery of visual function and cognition tests. We computed mean retinal layer thicknesses of both eyes within 1-, 2-, 3-, and 6-mm diameter macular discs and in concentric parafoveal (1- to 2-mm, 2- to 3-mm, 1- to 3-mm) and perifoveal (3- to 6-mm) rings. Group differences in imaging parameters and their relationship with visual outcomes were analyzed. A multivariate logistic model was developed to predict visual impairment from optical coherence tomography measurements in Parkinson's disease, and cutoff values were determined with receiver operating characteristic analysis.

Results: When compared with controls, patients with dementia with Lewy bodies had significant thinning of the ganglion cell-inner plexiform layer complex within the central 3-mm disc mainly because of differences in 1- to 3-mm parafoveal thickness. This parameter was strongly correlated in patients, but not in controls, with low contrast visual acuity and visual cognition outcomes (P < .05, False Discovery Rate), achieving 88% of accuracy in predicting visual impairment in Parkinson's disease.

Conclusion: Our findings support that parafoveal thinning of ganglion cell-inner plexiform complex is a sensitive and clinically relevant imaging biomarker for Lewy body diseases, specifically for Parkinson's disease. © 2019 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

Keywords: Parkinson's disease; dementia with Lewy bodies; macula; optical coherence tomography; visual dysfunction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cross-Sectional Studies
  • Female
  • Fovea Centralis / diagnostic imaging
  • Fovea Centralis / pathology*
  • Humans
  • Lewy Body Disease / complications*
  • Lewy Body Disease / genetics
  • Lewy Body Disease / pathology*
  • Macula Lutea / diagnostic imaging
  • Macula Lutea / pathology
  • Male
  • Middle Aged
  • Parkinson Disease / pathology
  • Reference Values
  • Retina / diagnostic imaging
  • Retina / pathology*
  • Retinal Ganglion Cells / pathology
  • Tomography, Optical Coherence
  • Treatment Outcome
  • Vision Disorders / diagnostic imaging
  • Vision Disorders / etiology*
  • Vision Disorders / pathology*
  • Visual Perception
  • alpha-Synuclein / genetics

Substances

  • SNCA protein, human
  • alpha-Synuclein